In lipid metabolism, the HIF-1α inhibitor YC-1, in combination with palmitic acid and L-carnitine, activates fatty acid β-oxidation and induces ROS overproduction, promoting liver cancer cell apoptosis [265]. The gene discussed is HIF1A; the disease is liver cancer.